Lisa LeCointe-Cephas - May 3, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
SVP Chief Ethics & Com Officer
Signature
/s/ Kelly E. W. Grez as attorney-in-fact for Lisa LeCointe-Cephas
Stock symbol
MRK
Transactions as of
May 3, 2023
Transactions value $
$116,534
Form type
4
Date filed
5/5/2023, 05:01 PM
Previous filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $81.2K +689 +16.58% $117.89 4.84K May 3, 2023 Direct
transaction MRK Common Stock Tax liability -$27.8K -236 -4.87% $117.89 4.61K May 3, 2023 Direct
transaction MRK Common Stock Options Exercise $96.1K +813 +17.64% $118.22 5.42K May 4, 2023 Direct
transaction MRK Common Stock Tax liability -$33K -279 -5.15% $118.22 5.14K May 4, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -689 -33.33% $0.00 1.38K May 3, 2023 Common Stock 689 Direct F1, F2
transaction MRK Restricted Stock Unit Options Exercise $0 -813 -49.91% $0.00 816 May 4, 2023 Common Stock 813 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024, and 5/3/2025.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.